NCT04482686View on ClinicalTrials.gov

Trial of Combination Therapy to Treat COVID-19 Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 9, 2020

Primary Completion Date

May 15, 2022

Study Completion Date

July 15, 2022

Conditions
COVIDCovid-19Corona Virus InfectionCoronavirus InfectionCoronavirus-19SARS-CoV2SARS-CoV Infection
Interventions
DRUG

Ivermectin

Treatment days 1, 4, and 8

DRUG

Doxycycline Hcl

10 day treatment

DIETARY_SUPPLEMENT

Zinc

10 Day treatment

DIETARY_SUPPLEMENT

Vitamin D3

10 day treatment

DIETARY_SUPPLEMENT

Vitamin C

10 day treatment

Trial Locations (1)

93003

ProgenaBiome, Ventura

Sponsors

Lead Sponsor

ProgenaBiome
All Listed Sponsors
lead

ProgenaBiome

OTHER

NCT04482686 - Trial of Combination Therapy to Treat COVID-19 Infection | Biotech Hunter | Biotech Hunter